Publications

  1. Stambaugh C, Gagneur J, Uejo A, Clouser E, Ezzell G. Improvements in treatment planning calculations motivated by tightening IMRT QA tolerances. J Appl Clin Med Phys. 2019 Jan; 20 (1):250-257 Epub 2018 Dec 31
    View PubMed
  2. Stambaugh C, Ezzell G. A clinically relevant IMRT QA workflow: Design and validation. Med Phys. 2018 Apr; 45 (4):1391-1399 Epub 2018 Mar 23
    View PubMed
  3. Ezzell G, Chera B, Dicker A, Ford E, Potters L, Santanam L, Weintraub S. Common error pathways seen in the RO-ILS data that demonstrate opportunities for improving treatment safety. Pract Radiat Oncol. 2018 Mar - Apr; 8 (2):123-132 Epub 2018 Jan 09
    View PubMed
  4. Liu W, Patel SH, Harrington DP, Hu Y, Ding X, Shen J, Halyard MY, Schild SE, Wong WW, Ezzell GE, Bues M. Exploratory study of the association of volumetric modulated arc therapy (VMAT) plan robustness with local failure in head and neck cancer. J Appl Clin Med Phys. 2017 Jul; 18 (4):76-83 Epub 2017 May 14
    View PubMed
  5. Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II. Adv Radiat Oncol. 2017 Jul-Sep; 2 (3):437-454 Epub 2017 Mar 20
    View PubMed
  6. Schild MH, Schild SE, Wong WW, Vora SA, Keole SR, Vargas CE, Daniels TB, Ezzell GA, Nguyen BD, Roarke MC. A Prospective Trial of Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Integrated Boost for Prostate Cancer: Long-term Outcomes Compared With Standard Image Guided IMRT. Int J Radiat Oncol Biol Phys. 2017 Apr 1; 97 (5):1021-1025 Epub 2017 Feb 01
    View PubMed
  7. Ezzell GA. The spatial accuracy of two frameless, linear accelerator-based systems for single-isocenter, multitarget cranial radiosurgery. J Appl Clin Med Phys. 2017 Mar; 18 (2):37-43 Epub 2017 Feb 02
    View PubMed
  8. Zaorsky NG, Showalter TN, Ezzell GA, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLaughlin PW, Movsas B, Prestidge BR, Taira AV, Vapiwala N, Davis BJ, Expert Panel on Radiation Oncology-Prostate:. ACR Appropriateness Criteria((R)) external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II. Adv Radiat Oncol. 2017 Jan-Mar; 2 (1):62-84 Epub 2016 Oct 20
    View PubMed
  9. Liu W, Patel SH, Shen JJ, Hu Y, Harrington DP, Ding X, Halyard MY, Schild SE, Wong WW, Ezzell GA, Bues M. Robustness quantification methods comparison in volumetric modulated arc therapy to treat head and neck cancer. Pract Radiat Oncol. 2016 Nov - Dec; 6 (6):e269-e275 Epub 2016 Feb 13
    View PubMed
  10. Ezzell GA. Response to "Comment on 'Medical physicist assistants are a bad idea' " [Med. Phys. 43, 1-3 (2016)]. Med Phys. 2016 Jul; 43 (7):4463
    View PubMed
  11. Fontenla DP, Ezzell GA. Medical physicist assistants are a bad idea. Med Phys. 2016 Jan; 43: (1)1.
    View PubMed
  12. Hoopes DJ, Dicker AP, Eads NL, Ezzell GA, Fraass BA, Kwiatkowski TM, Lash K, Patton GA, Piotrowski T, Tomlinson C, Ford EC. RO-ILS: Radiation Oncology Incident Learning System: A report from the first year of experience. Pract Radiat Oncol. 2015 Sep-Oct; 5 (5):312-318 Epub 2015 June 25
    View PubMed
  13. Gagneur JD, Ezzell GA. An improvement in IMRT QA results and beam matching in linacs using statistical process control. J Appl Clin Med Phys. 2014 Sep 8; 15 (5):4927 Epub 2014 Sept 08
    View PubMed
  14. Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer. J Urol. 2013 Aug; 190(2):521-6. Epub 2013 Feb 13.
    View PubMed
  15. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012 Oct 22; 7:174
    View PubMed
  16. Wong WW, Schild SE, Vora SA, Ezzell GA, Nguyen BD, Ram PC, Roarke MC. Image-guided radiotherapy for prostate cancer: a prospective trial of concomitant boost using indium-111-capromab pendetide (ProstaScint) imaging. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81 (4):e423-9 Epub 2011 Apr 07
    View PubMed
  17. Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. Cancer. 2009 Dec 1; 115(23):5596-606.
    View PubMed
  18. Ezzell GA, Burmeister JW, Dogan N, LoSasso TJ, Mechalakos JG, Mihailidis D, Molineu A, Palta JR, Ramsey CR, Salter BJ, Shi J, Xia P, Yue NJ, Xiao Y. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009 Nov; 36: (11)5359-73.
    View PubMed
  19. van Elmpt W, Ezzell GA, Orton CG. Point/Counterpoint. EPID dosimetry must soon become an essential component of IMRT quality assurance. Med Phys. 2009 Oct; 36 (10):4325-7
    View PubMed
  20. Chetty IJ, Curran B, Cygler JE, DeMarco JJ, Ezzell G, Faddegon BA, Kawrakow I, Keall PJ, Liu H, Ma CM, Rogers DW, Seuntjens J, Sheikh-Bagheri D, Siebers JV. Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys. 2007 Dec; 34 (12):4818-53
    View PubMed
  21. Vora SA, Wong WW, Schild SE, Ezzell GA, Halyard MY. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1053-8. Epub 2007 Mar 29.
    View PubMed
  22. Beddar AS, Biggs PJ, Chang S, Ezzell GA, Faddegon BA, Hensley FW, Mills MD. Intraoperative radiation therapy using mobile electron linear accelerators: report of AAPM Radiation Therapy Committee Task Group No. 72. Med Phys. 2006 May; 33(5):1476-89.
    View PubMed
  23. Schild SE, Korte SM, Wong WW, Vora SA, Younggren JA, Ezzell GA. Treatment planning for dose escalation in non-small cell lung cancer (NSCLC). Med Dosim. 2004 Fall; 29(3):196-203.
    View PubMed
  24. Galvin JM, Ezzell GA, Eisbrauch A, Yu C, Butler B, XiaoY, Rosen I, Rosenman, J, Sharpe M, Xing L, Xia P, Lomax T, Low D, Palta J. Implementing IMRT in Clinical Practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. International Journal of Rad Oncol Biol Phys. 2004; 58:1616-34.
  25. Ezzell GA. Shielding evaluation and acceptance testing of a prefabricated, modular, temporary radiation therapy treatment facility. J Appl Clin Med Phys. 2004; 5(4):120-5.
    View PubMed
  26. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, Xia P, Xiao Y, Xing L, Yu CX, IMRT subcommitte//AAPM Radiation Therapy committee. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys. 2003 Aug; 30: (8)2089-115.
    View PubMed
  27. Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Aug 1; 53 (5):1130-8
    View PubMed
  28. Ezzell GA, Chungbin S. The overshoot phenomenon in step-and-shoot IMRT delivery. J Appl Clin Med Phys. 2001 Summer; 2(3):138-48.
    View PubMed
  29. Herbert DE, Ezzell GA, Hendee WR. Medical physics education programs should include an in-depth course in statistics and mathematical modeling of human anatomy and physiology. Med Phys. 2001 May; 28(5):709-11.
    View PubMed
  30. Ezzell GA, Schild SE, Wong WW. Development of a treatment planning protocol for prostate treatments using intensity modulated radiotherapy. J Appl Clin Med Phys. 2001 Spring; 2 (2):59-68
    View PubMed
  31. Ezzell GA, Gaspar L. Application of a genetic algorithm to optimizing radiation therapy treatment plans for pancreatic carcinoma. Med Dosim. 2000 Summer; 25(2):93-7.
  32. Ezzell GA. A manual algorithm for computing dwell times for two-catheter endobronchial treatments using HDR brachytherapy. Med Phys. 2000 May; 27(5):1030-3.
    View PubMed
  33. Ezzell GA. Limitations of the straight line assumption for endobronchial HDR brachytherapy treatments. Med Phys. 2000; 27:151-3.
    View PubMed
  34. Aref A, Thornton D, Youssef E, He T, Tekyi-Mensah S, Denton L, Ezzell GA. Dosimetric improvements following 3D planning of tangential breast irradiation. International Journal of Rad Oncol Biol Phys. 2000; 48:1569-74.
  35. Gaspar LE, Zamorano LZ, Shamsa F, Fontanesi J, Ezzell GA, Yakar DA. Permanent Iodine-125 implants for recurrent malignant gliomas. International Journal of Rad Oncol Biol Phys. 1999; 43:977-82.
  36. Aref A, Ezzell G, Chuba P, Thornton D, Aref I. Tangential irradiation of the intact breast: the ABC of the technique. Med Dosim. 1998 Spring; 23(1):15-9.
  37. Ezzell GA. Genetic and geometric optimization of three-dimensional radiation therapy treatment planning. Med Phys. 1996 Mar; 23(3):293-305.
    View PubMed
  38. Han I, Ezzell GA, Orton CG. HDR brachytherapy for cancer of the cervix: technique and results. Activity. 1996; (Special Report No. 8):22-7.
  39. Maruyama Y, Ezzell G, Porter AT. Afterloading high dose rate intracavitary vaginal cylinder. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):473-6.
    View PubMed
  40. Ezzell GA. Quality assurance of treatment plans for optimized high dose rate brachytherapy--planar implants. Med Phys. 1994 May; 21(5):659-61.
    View PubMed
  41. Ezzell GA. Evaluation of new re-entrant ionization chambers for high-dose rate brachytherapy calibrations. Endocuriether Hypotherm Oncol. 1993; 9:233-8.
  42. Forman J, Orton CG, Ezzell GA, Porter AT. Hyperfractionated three-dimensional conformal radiotherapy for locally advanced adenocarcinoma of the prostate: preliminary results of a biologic dose escalation study. Radiother Oncol. 1993; 27:203-208.
    View PubMed
  43. Hamlet S, Ezzell GA, Aref A. Larynx Motion Associated with Swallowing During Radiation Therapy. International Journal of Rad Oncol Biol Phys. 1993; 28:467-70.
  44. Ahmad K, Kim YH, Ezzell GA, Han IH, Orton CG, Porter AT. Reproducibility of multifractionated outpatient high dose rate brachytherapy in carcinoma of the cervix utilizing the Ahmad-Kim positioner. Endocuriether Hypotherm Oncol. 1992; 8:171-3.
  45. Ezzell GA. The effect of alternative calibration procedures using NEL 2505/3 ionization chamber. Activity. 1991; 5:42-43.
  46. Ezzell GA. Quality assurance in HDR brachytherapy: physical and technical aspects. Activity. 1991; 5:59-68.
  47. Ahmad K, Kim YH, Kim H, Orton CG, Ezzell GA, Deppe G, Mesina CF, Warmelink C, Malone J, Malviya V, Christenson C, Han I, Ratanatharathorn V, Herskovic A. Fractionated high dose rate brachytherapy and concomitant teletherapy in the treatment of carcinoma of the cervix: technique and early results. Endocuriether Hypotherm Oncol. 1991; 7:117-24.
  48. Ezzell GA. Evaluation of calibration techniques for a high dose rate remote afterloading iridium-192 source. Endocuriether Hypotherm Oncol. 1990; 6:101-6.
  49. Ezzell GA. Calibration inter-comparison of an 192-IR source used for high dose rate remote afterloading. Activity. 1989; 1:10-13.
  50. Maughan RL, Blosser HG, Powers WE, Blosser EB, Blosser GF, Vincent J, Ezzell GA, Orton CG, Ragan DP. Progress with the superconducting cyclotron neutron therapy facility for Harper-Grace hospitals. Radiat Prot Dosimetry. 1988; 23:357-60.
  51. Campbell JM, Ezzell GA, Herron D, Powers WE, Orton CG. Coded dummy strands for treatment planning of iridium - 192 implants. Endocuriether Hypotherm Oncol. 1988; 5:107-110.
  52. Mesina CF, Ezzell GA, Campbell JM, Orton CG. Acceptance testing for the Selectron high dose rate remote afterloading cobalt-60 unit. Endocuriether Hypotherm Oncol. 1988; 4:253-6.
  53. Mesina CF, Ezzell GA, Campbell JM, Orton CG. Commissioning the Selectron HDR Co-60. Activity. 1988; 2:5-10.
  54. Ezzell GA, Orton CG, Maughan RL, Spicka JT, Vitalis TJ, Herskovic AM. Practical aspects of transmission cord blocks in radiotherapy. Med Phys. 1987 May-Jun; 14(3):400-5.
    View PubMed
  55. Herskovic AM, Ezzell GA, Orton CG, Lattin PB, Eisenbrey A, Thomas M, Lazo A, Muz J. Novel applications of phosphorus-32 in the treatment of cystic craniopharyngioma. Endocuriether Hypotherm Oncol. 1986; 2:129-35.
  56. Orton CG, Herskovic AM, Ezzell GA, Spicka JT, Vitalis T. Transmission blocks: clinical and biological rationales. Int J Radiat Oncol Biol Phys. 1985 Dec; 11(12):2155-8.
    View PubMed
  57. Vitalis TJ, Reid MD, Orton CG, Ezzell GA, Spicka JT. The application and design of transmission blocks in radiotherapy. American Association of Medical Dosimetrists Newsletter. 1985; 10(Number 2).